A detailed history of Susquehanna International Group, LLP transactions in Uni Qure N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 251,969 shares of QURE stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251,969
Previous 503,883 49.99%
Holding current value
$1.62 Million
Previous $2.62 Million 56.95%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$4.39 - $5.43 $1.11 Million - $1.37 Million
-251,914 Reduced 49.99%
251,969 $1.13 Million
Q1 2024

May 07, 2024

BUY
$4.82 - $6.93 $1.62 Million - $2.32 Million
335,159 Added 198.64%
503,883 $2.62 Million
Q4 2023

Feb 14, 2024

SELL
$5.63 - $8.27 $415,668 - $610,582
-73,831 Reduced 30.44%
168,724 $1.14 Million
Q3 2023

Nov 14, 2023

BUY
$6.71 - $11.83 $247,954 - $437,153
36,953 Added 17.97%
242,555 $1.63 Million
Q2 2023

Aug 11, 2023

BUY
$11.12 - $22.2 $1.02 Million - $2.03 Million
91,626 Added 80.39%
205,602 $2.36 Million
Q1 2023

May 16, 2023

SELL
$18.7 - $23.07 $2.37 Million - $2.92 Million
-126,743 Reduced 52.65%
113,976 $2.3 Million
Q4 2022

Feb 14, 2023

SELL
$18.12 - $27.32 $131,025 - $197,550
-7,231 Reduced 2.92%
240,719 $5.46 Million
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $686,857 - $1.03 Million
-40,451 Reduced 14.03%
247,950 $4.65 Million
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $763,265 - $1.19 Million
58,043 Added 25.2%
288,401 $5.38 Million
Q1 2022

May 16, 2022

BUY
$14.54 - $21.5 $1.34 Million - $1.98 Million
92,267 Added 66.82%
230,358 $4.16 Million
Q4 2021

Feb 14, 2022

BUY
$20.24 - $36.01 $312,890 - $556,678
15,459 Added 12.61%
138,091 $2.86 Million
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $2.03 Million - $2.98 Million
-77,975 Reduced 38.87%
122,632 $3.93 Million
Q2 2021

Aug 11, 2021

BUY
$29.97 - $37.17 $1.2 Million - $1.49 Million
40,066 Added 24.96%
200,607 $6.18 Million
Q1 2021

May 17, 2021

SELL
$29.24 - $42.03 $15,438 - $22,191
-528 Reduced 0.33%
160,541 $5.41 Million
Q4 2020

Feb 16, 2021

SELL
$35.35 - $50.67 $810,964 - $1.16 Million
-22,941 Reduced 12.47%
161,069 $5.82 Million
Q3 2020

Nov 16, 2020

SELL
$35.98 - $47.66 $1.92 Million - $2.55 Million
-53,494 Reduced 22.52%
184,010 $6.78 Million
Q2 2020

Aug 14, 2020

SELL
$45.06 - $67.74 $3.05 Million - $4.58 Million
-67,623 Reduced 22.16%
237,504 $10.7 Million
Q4 2019

Feb 14, 2020

SELL
$37.13 - $74.62 $5.03 Million - $10.1 Million
-135,479 Reduced 30.75%
305,127 $21.9 Million
Q2 2019

Aug 16, 2019

BUY
$52.76 - $82.19 $525,911 - $819,269
9,968 Added 2.31%
440,606 $34.4 Million
Q2 2019

Aug 14, 2019

BUY
$52.76 - $82.19 $8.83 Million - $13.8 Million
167,381 Added 63.58%
430,638 $33.7 Million
Q1 2019

May 15, 2019

BUY
$27.39 - $68.41 $4.69 Million - $11.7 Million
171,362 Added 186.48%
263,257 $15.7 Million
Q3 2018

Nov 14, 2018

SELL
$29.75 - $43.08 $4.28 Million - $6.2 Million
-143,934 Reduced 61.03%
91,895 $3.34 Million
Q2 2018

Aug 14, 2018

SELL
$21.96 - $39.94 $597,773 - $1.09 Million
-27,221 Reduced 10.35%
235,829 $8.91 Million
Q1 2018

May 15, 2018

SELL
$17.1 - $26.61 $463,102 - $720,652
-27,082 Reduced 9.33%
263,050 $6.18 Million
Q4 2017

Feb 14, 2018

BUY
$9.47 - $19.59 $2.75 Million - $5.68 Million
290,132
290,132 $5.68 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.